Who has been buying Kissei Pharmaceutical Co., Ltd. stock?

7 distinct investors have filed 6 disclosed large-shareholding filings in Kissei Pharmaceutical Co., Ltd. (4547), most recently on 2024-05-20. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Kissei Pharmaceutical Co., Ltd. have?

Kissei Pharmaceutical Co., Ltd. has 6 buy-side and 4 sell-side disclosures on record, covering ¥16.2B ($104.4M) in total reported value, spanning 2021-03-22 to 2024-05-20.

Do insider buys in Japanese stocks predict returns?

Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Kissei Pharmaceutical Co., Ltd. 4547

Company

キッセイ薬品工業株式会社Kissei Pharmaceutical Co., Ltd.

Investors

Buys

Total Value

¥16.2B ($104.4M)

Avg Return

+54.94%

Last Filing

2024-05-20

Kissei Pharmaceutical Co., Ltd. (4547) has 6 disclosed large-shareholding filings and 4 disclosed disposals on record, filed by 7 distinct investors. Together those filings cover ¥16.2B ($104.4M) in reported transaction value. The earliest filing StockDrifts holds for Kissei Pharmaceutical Co., Ltd. is dated 2021-03-22; the most recent is 2024-05-20. Across these filings the average return since disclosure is +54.94%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

Date	Type	Source	Insider	Purpose	Shares	Price at filing	Return	Value
2024-05-20	BUY	unknown	ブランデス・インベストメント・パートナーズ・エル・ピー(Brandes Investment Partners, L.P.) Brandes Investment Partners, L.P.	other	2.5M	¥3,160	+26.7%	¥8.0B ($51.8M)
2024-03-22	BUY	negotiated	株式会社長野銀行 Nagano Bank, Ltd.	strategic	0	¥3,575	-	-
2024-03-22	BUY	negotiated	八十二リース株式会社 Eighty Two Lease Co., Ltd.	strategic	137	¥3,575	-	-
2024-03-22	BUY	negotiated	株式会社八十二銀行 The Hachijuni Bank, Ltd.	strategic	2.2M	¥3,575	+12.0%	¥7.8B ($50.3M)
2024-01-05	BUY	Market Buy	株式会社八十二銀行 The Hachijuni Bank, Ltd.	strategic	2.3M	¥3,165	+26.5%	¥359M ($2.3M)
2024-01-05	SELL	Market Buy	株式会社長野銀行 Nagano Bank, Ltd.	strategic	461.8K	¥3,165	-26.5%	¥1.9B ($12.4M)
2024-01-05	BUY	Market Buy	八十二リース株式会社 Eighty Two Lease Co., Ltd.	strategic	137	¥3,165	-	-
2023-06-08	BUY	negotiated	株式会社八十二銀行 The Hachijuni Bank, Ltd.	strategic	2.3M	¥2,871	+39.5%	¥6.6B ($42.6M)
2023-06-08	BUY	negotiated	株式会社長野銀行 Nagano Bank, Ltd.	strategic	1.1M	¥2,871	+39.5%	¥3.2B ($20.9M)
2023-06-08	BUY	negotiated	八十二リース株式会社 Eighty Two Lease Co., Ltd.	strategic	137	¥2,871	+39.5%	¥393K ($3K)
2022-04-21	SELL	Market Buy	第一生命保険株式会社 The Dai-ichi Life Insurance Company, Limited	passive	2.5M	¥2,466	-62.4%	¥1.3B ($8.7M)
2021-03-22	SELL	unknown	株式会社みずほ銀行 Mizuho Bank, Ltd.	strategic	1.2M	¥2,401.149	-66.8%	¥1.2B ($8.0M)
2021-03-22	SELL	unknown	アセットマネジメントOne株式会社 Asset Management One Co., Ltd.	other	953.6K	¥2,401.149	-66.8%	¥361M ($2.3M)

Frequently asked questions

Who has been buying Kissei Pharmaceutical Co., Ltd. stock?: 7 distinct investors have filed 6 disclosed large-shareholding filings in Kissei Pharmaceutical Co., Ltd. (4547), most recently on 2024-05-20. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Kissei Pharmaceutical Co., Ltd. have?: Kissei Pharmaceutical Co., Ltd. has 6 buy-side and 4 sell-side disclosures on record, covering ¥16.2B ($104.4M) in total reported value, spanning 2021-03-22 to 2024-05-20.
Do insider buys in Japanese stocks predict returns?: Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.